Cite
HARVARD Citation
Abraham, A. et al. (2019). Baseline Decrement in Patients with Mild Myasthenia Gravis Predicts Immunomodulation Treatment. Canadian journal of neurological sciences. pp. 762-766. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abraham, A. et al. (2019). Baseline Decrement in Patients with Mild Myasthenia Gravis Predicts Immunomodulation Treatment. Canadian journal of neurological sciences. pp. 762-766. [Online].